Stockreport

Kodiak Sciences: A Stellar Move [Seeking Alpha]

Kodiak Sciences Inc  (KOD) 
Last kodiak sciences inc earnings: 11/12 05:30 am Check Earnings Report
PDF KOD's pipeline targets major retinal diseases, with pivotal Phase 3 data for tarcocimab, KSI-501, and KSI-101 expected between 2026 and 2027. Recent secondary raised [Read more]